Lanzhou Foci Pharmaceutical Co Ltd (002644) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lanzhou Foci Pharmaceutical Co Ltd (002644) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.62 Million ≈ $11.07 Million USD) by net assets (CN¥1.85 Billion ≈ $270.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002644 equity financing ratio to measure how much of total assets are equity-financed.
Lanzhou Foci Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Lanzhou Foci Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Lanzhou Foci Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Lanzhou Foci Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lanzhou Foci Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RaySearch Laboratories AB (publ)
ST:RAY-B
|
0.112x |
|
Haier Smart Home Co Ltd
XETRA:690D
|
0.049x |
|
ENCE Energía y Celulosa S.A
MC:ENC
|
-0.052x |
|
Jiangsu Alcha Aluminium Co Ltd
SHE:002160
|
-0.028x |
|
PMET Resources Inc.
TO:PMET
|
0.001x |
|
Integral Diagnostics Ltd
AU:IDX
|
0.074x |
|
Pasifik Gayrimenkul Yatirim Ortakligi AS
IS:PSGYO
|
-0.147x |
|
Shenzhen Sunxing Light Alloys
SHG:603978
|
-0.075x |
Annual Cash Flow Conversion Efficiency for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Lanzhou Foci Pharmaceutical Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.81 Billion ≈ $265.59 Million |
CN¥38.98 Million ≈ $5.70 Million |
0.021x | -42.20% |
| 2023-12-31 | CN¥1.77 Billion ≈ $258.78 Million |
CN¥65.71 Million ≈ $9.62 Million |
0.037x | -10.97% |
| 2022-12-31 | CN¥1.73 Billion ≈ $253.73 Million |
CN¥72.37 Million ≈ $10.59 Million |
0.042x | +472.99% |
| 2021-12-31 | CN¥1.63 Billion ≈ $238.15 Million |
CN¥11.85 Million ≈ $1.73 Million |
0.007x | -81.62% |
| 2020-12-31 | CN¥1.59 Billion ≈ $232.24 Million |
CN¥62.89 Million ≈ $9.20 Million |
0.040x | +24.86% |
| 2019-12-31 | CN¥1.51 Billion ≈ $220.51 Million |
CN¥47.82 Million ≈ $7.00 Million |
0.032x | +24.68% |
| 2018-12-31 | CN¥1.44 Billion ≈ $210.78 Million |
CN¥36.66 Million ≈ $5.36 Million |
0.025x | -47.92% |
| 2017-12-31 | CN¥1.36 Billion ≈ $198.89 Million |
CN¥66.42 Million ≈ $9.72 Million |
0.049x | +10.85% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.85 Million |
CN¥56.90 Million ≈ $8.33 Million |
0.044x | -15.17% |
| 2015-12-31 | CN¥1.23 Billion ≈ $180.52 Million |
CN¥64.11 Million ≈ $9.38 Million |
0.052x | -59.24% |
| 2014-12-31 | CN¥735.22 Million ≈ $107.59 Million |
CN¥93.75 Million ≈ $13.72 Million |
0.128x | +956.24% |
| 2013-12-31 | CN¥703.37 Million ≈ $102.93 Million |
CN¥-10.47 Million ≈ $-1.53 Million |
-0.015x | +8.69% |
| 2012-12-31 | CN¥675.53 Million ≈ $98.85 Million |
CN¥-11.02 Million ≈ $-1.61 Million |
-0.016x | -535.65% |
| 2011-12-31 | CN¥648.08 Million ≈ $94.84 Million |
CN¥2.43 Million ≈ $355.00K |
0.004x | -97.82% |
| 2010-12-31 | CN¥326.46 Million ≈ $47.77 Million |
CN¥56.18 Million ≈ $8.22 Million |
0.172x | +1156.35% |
| 2009-12-31 | CN¥252.96 Million ≈ $37.02 Million |
CN¥3.46 Million ≈ $507.01K |
0.014x | +392.85% |
| 2008-12-31 | CN¥216.81 Million ≈ $31.73 Million |
CN¥602.56K ≈ $88.17K |
0.003x | -99.49% |
| 2007-12-31 | CN¥195.20 Million ≈ $28.56 Million |
CN¥105.61 Million ≈ $15.45 Million |
0.541x | -- |
About Lanzhou Foci Pharmaceutical Co Ltd
LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing … Read more